Skip to content

Age and Sleep Apnea Syndrome

Age and Sleep Apnea Syndrome: Clinical Features and Outcomes

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03885440
Enrollment
3000
Registered
2019-03-21
Start date
2019-04-08
Completion date
2019-09-30
Last updated
2019-04-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Age Problem, OSA

Brief summary

By clinical record review, this retrospective study aims to compare the different age groups of patients with obstructive sleep apnea, who were diagnosed and treated in Taipei Veterans General Hospital, Taiwan.

Detailed description

This retrospective study aims to compare the characteristics of patients with obstructive sleep apnea (OSA). Patients with sleep problem and received a prior polysomnography at Taipei Veterans General Hospital during Jan. 1, 2016 to Dec. 31, 2017 will be enrolled. Obstructive sleep apnea (OSA) is defined by an apnea-hypopnea index(AHI) at least 5/hr with compatible symptoms. Their clinical record will be reviewed and data including demography, polysomnography, comorbidities and details related to upper airway structure will be collected. The charactereistics would be compared with Student's t tests, Mann-Whitney U tests, or Chi square tests if appropriated.

Interventions

OTHERAge

Age\<40 years old is chosen as the cutoff value.

OTHEROSA

The diagnosis of OSA (obstructive sleep apnea) relies on polysomnographic data showing an apnea-hypopnea index at least 5/hr with compatible symptoms.

Sponsors

Taipei Veterans General Hospital, Taiwan
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with sleep complaints and received PSG in sleep center in Taipei Veterans General Hospital

Exclusion criteria

* Patients who ever received treatment for OSA * Patients cannot tolerate PSG examination * Patients cannot complete the questionnaires before and after PSG examination

Design outcomes

Primary

MeasureTime frameDescription
Apnea-hypopnea index(AHI)through study completion, an average of 1 yearCounts of apnea/hypopnea events per hour

Secondary

MeasureTime frameDescription
Posterior airway space (PAS)through study completion, an average of 1 yearThe diameter from supramentale to gonion.
Number of participants with comorbiditiesthrough study completion, an average of 1 yearSelf-reported comorbidities including cardiovascular disease, stroke, hypertension, diabetes mellitus, hyperlipidemia, lung disease, anxiety, depression.
Body mass index(BMI)through study completion, an average of 1 yearThe body mass divided by the square of the body height.
arousal indexthrough study completion, an average of 1 yearThe number of arousals and awakenings as a frequency per hour of sleep.
oxygen desaturation indexthrough study completion, an average of 1 yearThe number of times per hour of sleep that the blood's oxygen level drop by 4% from baseline.
Sleep efficiencythrough study completion, an average of 1 yearThe ratio of the total time spent asleep (total sleep time) in a night compared to the total amount of time spent in bed.

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 11, 2026